These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 12679389

  • 1. Cardiac adrenergic activity is associated with left ventricular hypertrophy in genetically homogeneous subjects with hypertrophic cardiomyopathy.
    Sipola P, Vanninen E, Aronen HJ, Lauerma K, Simula S, Jääskeläinen P, Laakso M, Peuhkurinen K, Kuusisto J, Kuikka JT.
    J Nucl Med; 2003 Apr; 44(4):487-93. PubMed ID: 12679389
    [Abstract] [Full Text] [Related]

  • 2. Cine MR imaging of myocardial contractile impairment in patients with hypertrophic cardiomyopathy attributable to Asp175Asn mutation in the alpha-tropomyosin gene.
    Sipola P, Lauerma K, Jääskeläinen P, Laakso M, Peuhkurinen K, Manninen H, Aronen HJ, Kuusisto J.
    Radiology; 2005 Sep; 236(3):815-24. PubMed ID: 16014439
    [Abstract] [Full Text] [Related]

  • 3. Cardiac 123I-MIBG reflects left ventricular functional reserve in patients with nonobstructive hypertrophic cardiomyopathy.
    Isobe S, Izawa H, Iwase M, Nanasato M, Nonokawa M, Ando A, Ohshima S, Nagata K, Kato K, Nishizawa T, Murohara T, Yokota M.
    J Nucl Med; 2005 Jun; 46(6):909-16. PubMed ID: 15937299
    [Abstract] [Full Text] [Related]

  • 4. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.
    Zhao C, Shuke N, Yamamoto W, Okizaki A, Sato J, Ishikawa Y, Ohta T, Hasebe N, Kikuchi K, Aburano T.
    J Nucl Med; 2001 Jul; 42(7):1017-24. PubMed ID: 11438621
    [Abstract] [Full Text] [Related]

  • 5. Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy.
    Terai H, Shimizu M, Ino H, Yamaguchi M, Uchiyama K, Oe K, Nakajima K, Taki J, Kawano M, Mabuchi H.
    J Nucl Med; 2003 Oct; 44(10):1612-7. PubMed ID: 14530475
    [Abstract] [Full Text] [Related]

  • 6. First-pass MR imaging in the assessment of perfusion impairment in patients with hypertrophic cardiomyopathy and the Asp175Asn mutation of the alpha-tropomyosin gene.
    Sipola P, Lauerma K, Husso-Saastamoinen M, Kuikka JT, Vanninen E, Laitinen T, Manninen H, Niemi P, Peuhkurinen K, Jääskeläinen P, Laakso M, Kuusisto J, Aronen HJ.
    Radiology; 2003 Jan; 226(1):129-37. PubMed ID: 12511681
    [Abstract] [Full Text] [Related]

  • 7. Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation.
    Sipola P, Magga J, Husso M, Jääskeläinen P, Peuhkurinen K, Kuusisto J.
    Eur Radiol; 2011 Jul; 21(7):1383-9. PubMed ID: 21274714
    [Abstract] [Full Text] [Related]

  • 8. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
    Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, Biller L, Lesser JR, Udelson JE, Manning WJ, Appelbaum E.
    J Am Coll Cardiol; 2009 Jul 14; 54(3):220-8. PubMed ID: 19589434
    [Abstract] [Full Text] [Related]

  • 9. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R, Varma N, Child N, Goodman B, Jabbour A, Yu CY, Gebker R, Doltra A, Kelle S, Khan S, Rogers T, Arroyo Ucar E, Cummins C, Carr-White G, Nagel E, Puntmann VO.
    Circ Cardiovasc Imaging; 2015 Dec 14; 8(12):. PubMed ID: 26659373
    [Abstract] [Full Text] [Related]

  • 10. [Myocardial sympathetic activity and characteristics in hypertrophic cardiomyopathy: comparison with hypertensive hypertrophy].
    Narita M, Kurihara T.
    J Cardiol; 1996 Mar 14; 27(3):133-41. PubMed ID: 8865685
    [Abstract] [Full Text] [Related]

  • 11. Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study.
    Tuunanen H, Kuusisto J, Toikka J, Jääskeläinen P, Marjamäki P, Peuhkurinen K, Viljanen T, Sipola P, Stolen KQ, Hannukainen J, Nuutila P, Laakso M, Knuuti J.
    J Nucl Cardiol; 2007 Mar 14; 14(3):354-65. PubMed ID: 17556170
    [Abstract] [Full Text] [Related]

  • 12. Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes.
    Poutanen T, Tikanoja T, Jääskeläinen P, Jokinen E, Silvast A, Laakso M, Kuusisto J.
    Am Heart J; 2006 Mar 14; 151(3):725.e1-725.e9. PubMed ID: 16504640
    [Abstract] [Full Text] [Related]

  • 13. T-wave inversions related to left ventricular basal hypertrophy and myocardial fibrosis in non-apical hypertrophic cardiomyopathy: a cardiovascular magnetic resonance imaging study.
    Chen X, Zhao S, Zhao T, Lu M, Yin G, Jiang S, Prasad S.
    Eur J Radiol; 2014 Feb 14; 83(2):297-302. PubMed ID: 24332848
    [Abstract] [Full Text] [Related]

  • 14. Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers.
    Hughes RK, Camaioni C, Augusto JB, Knott K, Quinn E, Captur G, Seraphim A, Joy G, Syrris P, Elliott PM, Mohiddin S, Kellman P, Xue H, Lopes LR, Moon JC.
    J Am Heart Assoc; 2021 Aug 03; 10(15):e020227. PubMed ID: 34310159
    [Abstract] [Full Text] [Related]

  • 15. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease.
    Nagueh SF, McFalls J, Meyer D, Hill R, Zoghbi WA, Tam JW, Quiñones MA, Roberts R, Marian AJ.
    Circulation; 2003 Jul 29; 108(4):395-8. PubMed ID: 12860897
    [Abstract] [Full Text] [Related]

  • 16. Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy.
    Shimizu M, Ino H, Yamaguchi M, Terai H, Hayashi K, Nakajima K, Taki J, Mabuchi H.
    J Nucl Med; 2002 Jan 29; 43(1):15-20. PubMed ID: 11801697
    [Abstract] [Full Text] [Related]

  • 17. Enhanced washout of 99mTc-tetrofosmin in hypertrophic cardiomyopathy: quantitative comparisons with regional 123I-BMIPP uptake and wall thickness determined by MRI.
    Thet-Thet-Lwin, Takeda T, Wu J, Fumikura Y, Iida K, Kawano S, Yamaguchi I, Itai Y.
    Eur J Nucl Med Mol Imaging; 2003 Jul 29; 30(7):966-73. PubMed ID: 12756503
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy.
    Maron MS, Rowin EJ, Lin D, Appelbaum E, Chan RH, Gibson CM, Lesser JR, Lindberg J, Haas TS, Udelson JE, Manning WJ, Maron BJ.
    Circ Cardiovasc Imaging; 2012 Jul 29; 5(4):441-7. PubMed ID: 22563033
    [Abstract] [Full Text] [Related]

  • 19. Kinetics of 123I-MIBG after acute myocardial infarction and reperfusion therapy.
    Bengel FM, Barthel P, Matsunari I, Schmidt G, Schwaiger M.
    J Nucl Med; 1999 Jun 29; 40(6):904-10. PubMed ID: 10452304
    [Abstract] [Full Text] [Related]

  • 20. Sympathetic nervous function in patients with hypertrophic cardiomyopathy assessed by [123I]-MIBG: relationship with left ventricular perfusion and function.
    Pace L, Betocchi S, Losi MA, Della Morte AM, Ciampi Q, Nugnez R, Chiariello M, Salvatore M.
    Q J Nucl Med Mol Imaging; 2004 Mar 29; 48(1):20-5. PubMed ID: 15195000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.